Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. DCOY
DCOY logo

DCOY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DCOY News

Universe Pharma Acquires Patent Portfolio, Shares Surge

Jun 30 2026NASDAQ.COM

Decoy Therapeutics Secures $3.5 Million Funding

Jun 29 2026stocktwits

Universe Pharmaceuticals Acquires Best Praise International

Jun 29 2026Newsfilter

Decoy Therapeutics Secures $3.5M PIPE Financing to Advance Antiviral Candidate

Jun 29 2026seekingalpha

Decoy Therapeutics Secures $3.5 Million PIPE Financing

Jun 29 2026NASDAQ.COM

Decoy Therapeutics Secures $3.5 Million PIPE Financing

Jun 27 2026PRnewswire

Decoy Therapeutics Secures $3.5 Million PIPE Financing

Jun 27 2026Newsfilter

Decoy Therapeutics Nominates New Director

Jun 03 2026PRnewswire

Decoy Therapeutics Partners with hVIVO for D-MAV Clinical Development

Jun 01 2026NASDAQ.COM

Decoy Therapeutics Initiates Clinical Studies for New Antiviral Category

Jun 01 2026PRnewswire

Decoy Appoints New Chair of Scientific Advisory Board

May 26 2026PRnewswire

Biotech Stocks Surge with Akari Leading the Rally

May 26 2026NASDAQ.COM

Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston

Apr 27 2026PRnewswire

Decoy Therapeutics Launches Multi-Virus Antiviral Platform

Apr 09 2026PRnewswire

Decoy Therapeutics Launches Multi-Viral Antiviral Platform

Apr 09 2026Newsfilter

Decoy Therapeutics CEO to Participate in Investor Event

Apr 06 2026PRnewswire